Will Celcuity's VIKTORIA-1 Hit The Target?

Shares of Celcuity Inc. (CELC) are down 34% from their 52-week high of $14.40, recorded in January of this year, to trade around $9..

Related Keywords

Nubeqa Darolutamide ,Pfizer ,Nasdaq ,Celcuity Inc ,Planned Trials ,Anticipated Milestones ,Cancer ,Fda Approval ,Elcuity ,Elc ,